SEC Form 4 · accession 0001127602-18-027110
Elevance Health, Inc. · ELV
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Peter D Haytaian
Officer — EVP & President, Commercial
Period of report
Sep 6, 2018
Accepted (ET)
Sep 7, 2018 · 4:36 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001156039
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Sep 6, 2018 | M | 1,936 | $60.15 | A | 58,642 | D | |
| Common Stock | Sep 6, 2018 | S | 1,936 | $270.00 | D | 56,706 | D | |
| Common Stock | Sep 6, 2018 | S | 1,000 | $270.00 | D | 55,706 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (Right to Buy)F3 | $60.15 | Sep 6, 2018 | M | 1,936 | D | — | Sep 28, 2019 | Common Stock | 1,936 | 0 | D |
Explanation of responses
- F1The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 9, 2018.
- F2The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on July 26, 2018.
- F3The option represents a right to purchase a total of 3,870 shares, and is exercisable in four annual installments, with two installments of 967 shares each and two installments of 968 shares each, beginning on December 31, 2012 which is the three-month anniversary of the option grant date.